Offer - Urjas Oil for just ₹ 1
Carzec 6.25 Tablet is a prescription medicine that is available as a Tablet. High BP are some of its major therapeutic uses. Secondary and off-label uses of Carzec 6.25 Tablet have also been mentioned below.
The right dosage of Carzec 6.25 Tablet depends on the age, gender, and medical history of the patient. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
Apart from the aforementioned side effects, Carzec 6.25 Tablet can also lead to other problems, which have been listed below. These side effects of Carzec 6.25 Tablet are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Carzec 6.25 Tablet is Moderate for pregnant women and Safe for women who are breastfeeding. Further, the section on Carzec 6.25 Tablet related warnings talks about Carzec 6.25 Tablet's effects on the liver, heart and kidney.
Carzec 6.25 Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Diabetes, Bradycardia (Slow Heart Rate), Peripheral Vascular Disease (PVD) are examples of such conditions. Other contraindications of Carzec 6.25 Tablet have been discussed in the sections ahead.
Drug interactions for Carzec 6.25 Tablet have been reported in the medical literature. A complete list of these interactions is given below.
In addition to the above precautions for Carzec 6.25 Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Carzec 6.25 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Carzec 6.25 Tablet is used -
Severe
Moderate
Mild
Is the use of Carzec 6.25 Tablet safe for pregnant women?
Carzec can have harmful effects in pregnant women. If you experience any discomfort after using Carzec, then discontinue the use and take your doctor's advice.
Is the use of Carzec 6.25 Tablet safe during breastfeeding?
Breastfeeding women can safely use Carzec.
What is the effect of Carzec 6.25 Tablet on the Kidneys?
Using Carzec does not have any harmful effects on kidneys.
What is the effect of Carzec 6.25 Tablet on the Liver?
Carzec may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Carzec 6.25 Tablet on the Heart?
Carzec may have mild side effects on the heart. Most people will never see any effect on the heart.
Carzec 6.25 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Carzec 6.25 Tablet unless your doctor advises you to do so -
Is this Carzec 6.25 Tablet habit forming or addictive?
No, you will not get addicted to Carzec 6.25 Tablet.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Carzec 6.25 Tablet can make you feel drowsy.
Is it safe?
Yes, but take Carzec 6.25 Tablet only as per medical advice.
Is it able to treat mental disorders?
No, Carzec 6.25 Tablet cannot treat any kind of mental disorder.
Interaction between Food and Carzec 6.25 Tablet
Eating certain foods may increase the time it takes Carzec 6.25 Tablet to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Carzec 6.25 Tablet
Consult your doctor before consuming alcohol while taking Carzec 6.25 Tablet as it can have severe side effects.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 287-288
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 564
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Coreg® (carvedilol)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Coreg Cr® (carvedilol phosphate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Vedilol® (carvedilol)
